Dihydroquercetin regulated PPARγ/AVPR1A/PLCB1/PLA2 pathway to alleviate the colitis of DSS mice.
Inflammatory bowel disease (IBD) is a global disease with limited therapy. It is reported that dihydroquercetin (DHQ) exerts anti-oxidative, anti-inflammatory and cell-protective properties as a natural occurring flavonoid compound, but its effects on IBD remain unclear. In this study, the mice were administered DHQ or...